About the Lab

Under the leadership of Iftikhar J. Kullo, M.D., the Atherosclerosis and Lipid Genomics Laboratory at Mayo Clinic focuses its research efforts on better understanding the genetics of atherosclerotic cardiovascular diseases, including coronary heart disease, peripheral artery disease and abdominal aortic aneurysm, and on hereditary lipid disorders, including familial hypercholesterolemia.

Dr. Kullo and his research team in the lab, along with numerous research collaborators, are engaged in ongoing research studies related to genomic discovery and implementation of genomic medicine leveraging the electronic health record.

The laboratory also investigates circulating biomarkers and assays of arterial function as a means of refining cardiovascular risk estimates.

About Dr. Kullo

Dr. Kullo is a consultant and an esteemed professor of medicine at Mayo Clinic in Rochester, Minnesota.

Dr. Kullo graduated from the Government Medical College in Srinagar, Kashmir, India, and completed residency in internal medicine and a fellowship in cardiology at Mayo Clinic. He joined the faculty of Mayo Clinic in 1999.

In addition to heading the Atherosclerosis and Lipid Genomics Lab, Dr. Kullo is the director of the Early Atherosclerosis and Familial Hypercholesterolemia clinics at Mayo Clinic.

Dr. Kullo is widely published in the fields of cardiovascular genomic discovery and implementation, cardiovascular biomarkers, atherosclerosis, arterial stiffness and vascular medicine. Dr. Kullo is involved in the education of medical students and residents and in continuing medical education programs through the Mayo Clinic School of Continuous Professional Development.

Research in Dr. Kullo's Atherosclerosis and Lipid Genomics Lab is funded by the National Human Genome Research Institute, the National Heart, Lung, and Blood Institute and other organizations.